vTv Therapeutics Inc. (VTVT)
19.66
1.26 (6.85%)
At close: Feb 28, 2025, 3:53 PM
19.66
0.00%
After-hours: Feb 28, 2025, 03:53 PM EST
vTv Therapeutics Balance Sheet Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
| Cash & Equivalents | 9.45M | 12.13M | 13.41M | 5.75M | 1.78M | 1.68M | 11.76M | 51.51M | 88M | 1.38M | 1.09M |
| Short-Term Investments | 65K | 15K | 100K | 371K | 250K | 1.12M | n/a | n/a | n/a | n/a | 69K |
| Long-Term Investments | n/a | 5.59M | 9.17M | 6.72M | 2.48M | 2.48M | 2.48M | n/a | 49K | n/a | n/a |
| Other Long-Term Assets | n/a | -6.14M | n/a | -7.57M | 2.94M | 2.54M | 4.79M | 1.93M | 1.67M | 7.56M | 7.29M |
| Receivables | 102K | 12.42M | 57K | 158K | 5K | n/a | 8M | n/a | 69K | n/a | 215K |
| Inventory | n/a | 15K | 100K | 371K | 250K | n/a | 162K | n/a | n/a | n/a | 130K |
| Other Current Assets | 1.11M | 2.54M | 2.15M | 939K | 1.06M | 1.79M | 442K | 1.22M | 2.23M | 227K | 1.05M |
| Total Current Assets | 10.66M | 27.09M | 15.62M | 7.21M | 2.84M | 3.47M | 20.36M | 52.12M | 89.19M | 1.61M | 2.42M |
| Property-Plant & Equipment | 361K | 556K | 680K | 849K | 1M | 70K | 283K | 444K | 624K | 3.78M | 5.79M |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 361K | 6.14M | 9.85M | 7.57M | 6.43M | 5.09M | 7.55M | 2.38M | 2.35M | 11.34M | 13.08M |
| Total Assets | 11.02M | 33.24M | 25.47M | 14.79M | 9.27M | 8.56M | 27.92M | 54.49M | 91.53M | 12.95M | 15.5M |
| Account Payables | 4.08M | 2.46M | 1.88M | 1.93M | 2.23M | 2.9M | 2.27M | 3.06M | 4.14M | 2.66M | 4.83M |
| Deferred Revenue | 17K | 17K | 35K | 31K | 31K | 1.75M | 8.76M | 21K | 219K | 2.8M | 137K |
| Short-Term Debt | 360K | 532K | 624K | 394K | 6.39M | 9.38M | 4.27M | n/a | n/a | 155K | 80.91M |
| Other Current Liabilities | 6.17M | 4.7M | 5.96M | 4.04M | 4.73M | 4.8M | 11.63M | 8.35M | 3.37M | 4.05M | 1.71M |
| Total Current Liabilities | 10.62M | 7.71M | 8.5M | 6.39M | 13.38M | 18.84M | 26.93M | 11.43M | 7.73M | 6.86M | 87.58M |
| Long-Term Debt | 169K | 338K | 492K | 676K | 831K | 6.33M | 15.32M | 11.06M | n/a | 36.01M | 2.27M |
| Other Long-Term Liabilities | 110K | 684K | 1.26M | 3.93M | 2.86M | 2.7M | 782K | 433K | 245K | 30.79M | 229.39M |
| Total Long-Term Liabilities | 18.95M | 36.27M | 26.72M | 88.5M | 44.91M | 72.58M | 152.03M | 134.01M | 161.78M | 504.89M | 231.65M |
| Total Liabilities | 29.57M | 43.98M | 35.21M | 94.89M | 58.29M | 91.41M | 178.96M | 145.44M | 169.5M | 511.76M | 319.24M |
| Total Debt | 529K | 716K | 932K | 915K | 7.11M | 15.71M | 19.59M | 11.06M | n/a | 36.17M | 83.17M |
| Common Stock | 27K | 1.05M | 901K | 773K | 641K | 435K | 329K | 329K | 329K | n/a | n/a |
| Retained Earnings | -281.04M | -265.52M | -248.83M | -290.04M | -233.52M | -233.88M | -279.06M | -215.49M | -195.99M | -498.81M | -303.73M |
| Comprehensive Income | n/a | n/a | n/a | n/a | n/a | -8.43M | -9.12M | -10.45M | -11.09M | -11.84M | -14.28M |
| Shareholders Equity | -24.68M | -10.74M | -9.74M | -80.1M | -49.02M | -82.85M | -151.05M | -90.94M | -77.97M | -498.81M | -303.73M |
| Total Investments | 65K | 5.59M | 9.17M | 6.72M | 2.48M | 2.48M | 2.48M | n/a | 49K | n/a | 69K |